Abstract

Although it is clear that transforming growth factor-beta1 (TGF-beta1) is critical for renal fibrogenesis, the complexity of the involved mechanisms is increasingly apparent. TGF-beta1 stimulates phosphorylation of Smad2/3 and activates other signaling molecules as well. The molecular link between these other kinases and Smads is not known. We sought new binding partners for Smad3 in renal cells and identified receptor for activated protein kinase C 1 (RACK1) as a novel binding partner of Smad3. The linker region of Smad3 and the tryptophan-aspartic acid repeat 6 and 7 of RACK1 are sufficient for the association. RACK1 also interacts with Smad3 in the human kidney epithelial cell line, HKC. Silencing RACK1 increases transcriptional activity of TGF-beta1-responsive promoter sequences of the Smad binding element (SBE), p3TP-Lux, and alpha2(I) collagen. Conversely, overexpressed RACK1 negatively modulates alpha2(I) collagen transcriptional activity in TGF-beta1-stimulated cells. RACK1 did not affect phosphorylation of Smad3 at the C terminus or in the linker region. However, RACK1 reduced direct binding of Smad3 to the SBE motif. Mutating a RACK1 tyrosine at residue 246, but not at 228, decreased the inhibitory effect of RACK1 on both alpha2(I) collagen promoter activity and Smad binding to SBE induced by TGF-beta1. These results suggest that RACK1 modulates transcription of alpha2(I) collagen by TGF-beta1 through interference with Smad3 binding to the gene promoter.

Highlights

  • The importance of transforming growth factor-␤ (TGF-␤)2 as a mediator of glomerular extracellular matrix (ECM) accumulation in kidney disease has been widely investigated [1, 2]

  • We found that in human mesangial cells, the extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein (MAP) kinases are activated by TGF-␤1 within 15–30 min

  • Multiple signal transduction pathways induced by TGF-␤1 have been studied for their ability to regulate ECM in the kidney

Read more

Summary

Introduction

The importance of transforming growth factor-␤ (TGF-␤)2 as a mediator of glomerular extracellular matrix (ECM) accumulation in kidney disease has been widely investigated [1, 2]. Silencing RACK1 increases transcriptional activity of TGF-␤1-responsive promoter sequences of the Smad binding element (SBE), p3TP-Lux, and ␣2(I) collagen. Mutating a RACK1 tyrosine at residue 246, but not at 228, decreased the inhibitory effect of RACK1 on both ␣2(I) collagen promoter activity and Smad binding to SBE induced by TGF-␤1.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call